$56.56
-0.12-0.20%
Last update: Dec 15, 3:05 PM
Comments
Loading...
CRISPR Therapeutics Short Interest Report
CRSPNASDAQ
CRISPR Therapeutics Stock Short Interest Report | NASDAQ:CRSP | Benzinga
Short interest in CRISPR Therapeutics AG (NASDAQ:CRSP) decreased during the last reporting period, falling from 23.19M to 22.43M. This put 26.42% of the company's publicly available shares short.
Based on the recent average volume of 2.43M shares traded per day, it would take 9.25 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.
Short Interest
22.43M
Short Interest %
26.4%
Days to Cover
9.25
| Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG Common | 11/28/2025 | 12/09/2025 | 26.42% | 84,890,925 | 22,431,985 | 2,425,038 | 9.25 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 11/14/2025 | 11/25/2025 | 27.31% | 84,890,925 | 23,186,755 | 2,707,148 | 8.57 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 10/31/2025 | 11/11/2025 | 24.78% | 84,890,925 | 21,033,230 | 2,126,012 | 9.89 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 10/15/2025 | 10/24/2025 | 26.13% | 80,541,115 | 21,048,713 | 3,100,438 | 6.79 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 09/30/2025 | 10/09/2025 | 26.51% | 80,541,115 | 21,354,942 | 2,773,028 | 7.7 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 09/15/2025 | 09/24/2025 | 29.56% | 80,541,115 | 23,811,876 | 1,884,778 | 12.63 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 08/29/2025 | 09/10/2025 | 27.41% | 80,541,115 | 22,074,375 | 1,738,538 | 12.7 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 08/15/2025 | 08/26/2025 | 28.94% | 80,541,115 | 23,309,013 | 3,229,899 | 7.22 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 07/31/2025 | 08/11/2025 | 29.11% | 80,541,115 | 23,446,400 | 4,056,955 | 5.78 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 07/15/2025 | 07/24/2025 | 33.30% | 75,954,376 | 25,295,875 | 3,279,650 | 7.71 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 06/30/2025 | 07/10/2025 | 33.63% | 75,954,376 | 25,542,468 | 4,384,022 | 5.83 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 06/13/2025 | 06/25/2025 | 28.19% | 75,954,376 | 21,409,921 | 2,524,184 | 8.48 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 05/30/2025 | 06/10/2025 | 27.04% | 75,954,376 | 20,539,111 | 1,933,171 | 10.62 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 05/15/2025 | 05/27/2025 | 27.73% | 75,954,376 | 21,065,431 | 2,131,226 | 9.88 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 04/30/2025 | 05/09/2025 | 28.07% | 75,954,376 | 21,319,453 | 1,570,304 | 13.58 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 04/15/2025 | 04/25/2025 | 27.34% | 75,953,854 | 20,764,751 | 2,871,127 | 7.23 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 03/31/2025 | 04/09/2025 | 27.08% | 75,728,599 | 20,510,014 | 1,760,536 | 11.65 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 03/14/2025 | 03/25/2025 | 26.82% | 75,728,599 | 20,307,836 | 1,691,868 | 12 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 02/28/2025 | 03/11/2025 | 27.48% | 75,728,599 | 20,808,121 | 2,762,173 | 7.53 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 02/14/2025 | 02/26/2025 | 26.95% | 75,728,599 | 20,407,467 | 2,657,292 | 7.68 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 01/31/2025 | 02/11/2025 | 25.88% | 75,307,604 | 19,491,883 | 2,080,983 | 9.37 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 01/15/2025 | 01/27/2025 | 26.97% | 75,307,604 | 20,311,420 | 1,803,942 | 11.26 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 12/31/2024 | 01/10/2025 | 25.36% | 75,307,604 | 19,097,155 | 1,799,431 | 10.61 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 12/13/2024 | 12/24/2024 | 24.06% | 75,307,604 | 18,116,755 | 2,033,615 | 8.91 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 11/29/2024 | 12/10/2024 | 24.11% | 75,307,604 | 18,153,184 | 1,573,441 | 11.54 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 11/15/2024 | 11/26/2024 | 25.75% | 75,307,604 | 19,390,540 | 2,161,975 | 8.97 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 10/31/2024 | 11/11/2024 | 24.68% | 75,307,604 | 18,587,119 | 1,152,226 | 16.13 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 10/15/2024 | 10/24/2024 | 23.42% | 75,122,283 | 17,592,960 | 956,558 | 18.39 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 09/30/2024 | 10/09/2024 | 23.38% | 75,122,283 | 17,560,892 | 1,149,590 | 15.28 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 09/13/2024 | 09/24/2024 | 23.35% | 75,122,283 | 17,543,484 | 912,940 | 19.22 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 08/30/2024 | 09/11/2024 | 23.21% | 75,122,283 | 17,439,381 | 873,074 | 19.97 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 08/15/2024 | 08/26/2024 | 22.86% | 75,122,283 | 17,174,029 | 1,529,441 | 11.23 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 07/31/2024 | 08/09/2024 | 21.87% | 75,122,283 | 16,428,259 | 1,345,272 | 12.21 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 07/15/2024 | 07/24/2024 | 21.52% | 74,872,218 | 16,115,832 | 1,126,602 | 14.3 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 06/28/2024 | 07/10/2024 | 20.91% | 74,872,218 | 15,652,762 | 1,431,314 | 10.94 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 06/14/2024 | 06/26/2024 | 19.86% | 74,872,218 | 14,866,549 | 1,448,128 | 10.27 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 05/31/2024 | 06/11/2024 | 20.92% | 74,872,218 | 15,660,985 | 1,014,070 | 15.44 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 05/15/2024 | 05/24/2024 | 20.48% | 74,872,218 | 15,334,922 | 1,552,550 | 9.88 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 04/30/2024 | 05/09/2024 | 19.48% | 74,872,218 | 14,586,850 | 1,299,948 | 11.22 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 04/15/2024 | 04/24/2024 | 19.70% | 74,837,216 | 14,744,982 | 1,275,409 | 11.56 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 03/28/2024 | 04/09/2024 | 19.72% | 74,837,216 | 14,757,233 | 1,210,457 | 12.19 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 03/15/2024 | 03/26/2024 | 18.59% | 79,226,030 | 14,724,239 | 1,446,048 | 10.18 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 02/29/2024 | 03/11/2024 | 19.01% | 79,226,030 | 15,061,974 | 2,562,232 | 5.88 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 02/15/2024 | 02/27/2024 | 18.77% | 79,226,030 | 14,874,679 | 2,491,670 | 5.97 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 01/31/2024 | 02/09/2024 | 20.08% | 78,382,526 | 15,740,331 | 1,770,074 | 8.89 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 01/12/2024 | 01/24/2024 | 21.74% | 78,382,526 | 17,038,104 | 2,262,624 | 7.53 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 12/29/2023 | 01/10/2024 | 20.73% | 78,382,526 | 16,250,367 | 2,390,400 | 6.8 | Get Alert |
| CRSP | CRISPR Therapeutics AG Common | 12/15/2023 | 12/27/2023 | 22.10% | 78,382,526 | 17,325,024 | 4,803,895 | 3.61 | Get Alert |
Looking for the most shorted stocks?
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved